-
1دورية أكاديمية
المؤلفون: Armstrong, W B, Kennedy, A R, Wan, X S, Atiba, J, McLaren, C E, Meyskens, F L, Jr
المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 9(1)
مصطلحات موضوعية: Administration, Oral, Aged, Anticarcinogenic Agents: administration & dosage, adverse effects, pharmacokinetics, therapeutic use, urine, Biological Markers: analysis, Chemoprevention, Chymotrypsin: antagonists & inhibitors, Endopeptidases: analysis, Female, Follow-Up Studies, Humans, Leukoplakia, Oral: drug therapy, Male, Middle Aged, Mouth Mucosa: enzymology, Trypsin Inhibitor, Bowman-Birk Soybean: administration & dosage, adverse effects, pharmacokinetics, therapeutic use, urine, Trypsin Inhibitors: administration & dosage, adverse effects, pharmacokinetics, therapeutic use, urine, antineoplastic agent, Bowman Birk inhibitor, adult, aged, article, clinical article, clinical trial, controlled clinical trial, controlled study, dose response, drug blood level, drug formulation, drug metabolism, drug safety, drug tolerability, drug urine level, female, human, leukoplakia, male, priority journal, Administration, Oral, Aged, Anticarcinogenic Agents, Biological Markers, Chemoprevention, Chymotrypsin, Endopeptidases, Female, Follow-Up Studies, Humans, Leukoplakia, Oral, Male, Middle Aged, Mouth Mucosa, Trypsin Inhibitor, Bowman-Birk Soybean, Trypsin Inhibitors
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/4k66t6k4
-
2مورد إلكتروني
المصدر: Armstrong, W B; Kennedy, A R; Wan, X S; Atiba, J; McLaren, C E; & Meyskens, F L Jr. (2000). Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 9(1), 43 - 47. UC Irvine: Retrieved from:
مصطلحات الفهرس: Medicine and Health Sciences, Administration, Oral, Aged, Anticarcinogenic Agents: administration & dosage, adverse effects, pharmacokinetics, therapeutic use, urine, Biological Markers: analysis, Chemoprevention, Chymotrypsin: antagonists & inhibitors, Endopeptidases: analysis, Female, Follow-Up Studies, Humans, Leukoplakia, Oral: drug therapy, Male, Middle Aged, Mouth Mucosa: enzymology, Trypsin Inhibitor, Bowman-Birk Soybean: administration & dosage, Trypsin Inhibitors: administration & dosage, antineoplastic agent, Bowman Birk inhibitor, adult, aged, article, clinical article, clinical trial, controlled clinical trial, controlled study, dose response, drug blood level, drug formulation, drug metabolism, drug safety, drug tolerability, drug urine level, female, human, leukoplakia, male, priority journal, Anticarcinogenic Agents, Biological Markers, Chymotrypsin, Endopeptidases, Mouth Mucosa, Bowman-Birk Soybean, Trypsin Inhibitors, article
